Brit Long

Current Controversies in TIA Evaluation

TIA is a brief neurologic deficit due to cerebral ischemia, with no permanent infarction. It affects over 200,000 U.S. patients per year and may precede 14% to 23% of strokes. Many have sought risk stratification tools to determine who may be appropriate for discharge with follow-up. This post evaluates the new ACEP guidelines for TIA and the controversies in the ED evaluation of TIA.

Current Controversies in TIA Evaluation Read More »

The Controversies of Corticosteroids in Sepsis

Sepsis is a condition emergency providers manage daily and has the potential for high morbidity and mortality. Sepsis management requires rapid diagnosis, early administration of intravenous (IV) fluids with broad-spectrum antimicrobials, and source control. But what is the role for steroids in sepsis? What are the potential benefits and risks? This post will explore the evidence surrounding corticosteroids in sepsis management to help shed some light on this controversial topic.

The Controversies of Corticosteroids in Sepsis Read More »

Chest Pain Controversies: Coronary CTA Use (Part 2)

Coronary CTA has risen to the forefront of chest pain evaluation, providing an anatomical evaluation of coronary artery vasculature. When negative, it improves negative predictive value of ACS. Additionally, CCTA allows for a better means to diagnose CAD when compared to history, physical exam, ECG, and biomarkers. But, is CCTA useful to further risk stratify low-risk patients? Who might benefit from CCTA and what are the risks?

Chest Pain Controversies: Coronary CTA Use (Part 2) Read More »

Chest Pain Controversies: Risk Stratification and Stress Test Utility (Part 1)

Chest pain accounts for approximately 8-10 million healthcare visits in the U.S. per year and can be associated with a variety of benign to life-threatening diseases. Acute coronary syndrome is one of the major considerations in the ED. Approximately 20% of lawsuits are due to misdiagnosis and mismanagement of ACS and a large percentage of patients are admitted due to this risk. However, few admitted patients go on to be diagnosed with ACS. Although commonly used to help risk stratify patients in the ED, there is no evidence that stress testing decreases risk of future cardiac events. This post will examine chest pain risk stratification in the ED and the utility of stress testing.

Chest Pain Controversies: Risk Stratification and Stress Test Utility (Part 1) Read More »

Dublin ireland shopping center archives – english. Gallery shanti welfare. Fingerlings : hangin' with gigi | gigi the unicorn misbehaves at a tea party it's a unicorn store.